Matthew De Silva

What they invest in

Matthew De Silva is a Venture Partner at Builders VC, with an investment range of $100K to $5.0M, focusing on areas like Digital Health (Series A), BioTech (Series A), Health & Hospital Services (Series A), and Health IT (Series A). Recent investments include Eigen Therapeutics, Arpeggio Bio, and Enveda Biosciences. His sweet spot for investments is $1.5M, and he collaborates with various co-investors. His partners include Ludwig Schulze, Josh Kopelman, Milad Alucozai, Kevin Mahaffey, and more. Matthew's investments are in collaboration with investors like Alison Sunstrum, [name locked], and others.

Who works there

7 people on file: 7 with an email address, 2 with a phone number, 6 with a professional profile. Names and details are behind a free account.

No card. Each contact is charged once and stays yours.